Quick Answer
Organon & Co. reported Long-Term Debt of $8.63 billion for fiscal year 2025.
Organon & Co. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $8.63B | -2.6% |
| 2024 | $8.86B | +1.2% |
| 2023 | $8.75B | -1.7% |
| 2022 | $8.90B | -2.4% |
| 2021 | $9.12B | — |
| 2020 | $0.00 | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $8.78B | +0.5% | +0.0% |
| June 30, 2025 | $8.78B | +1.5% | -1.7% |
| March 31, 2025 | $8.94B | +2.7% | +0.9% |
| December 31, 2024 | $8.86B | +1.2% | +1.4% |
| September 30, 2024 | $8.74B | +1.1% | +1.1% |
| June 30, 2024 | $8.65B | -0.9% | -0.7% |
| March 31, 2024 | $8.71B | +0.0% | -0.5% |
| December 31, 2023 | $8.75B | -1.7% | +1.2% |
- Organon & Co. showed a decrease of -2.6% in Long-Term Debt compared to the prior fiscal year.
- The most recent figure is from Organon & Co.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: